arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Cosmos Health Inc.

COSM
$0.41 ▲ +0.05 (+15.21%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
70 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Bearish
auto_awesome

Analytical Summary

Cosmos Health Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $24.6M
Dividend Yield
Revenue Growth 28.8%
Op. Margin -15.4%
ROIC -12.3%
FCF / Share $-0.03
Trailing P/E
Price / Book 1.6x
FCF Yield
Debt / Equity 0.15
info Valuation on last close. End-of-day price, Sep 23, 2026.

70-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$18.99M
↑ +28.8%
Net Income Profit after all expenses
$-2.81M
↑ +0.8%
Operating Margin Operating profit as % of sales
-15.4%
↓ -26.5% 9th
FCF / Share Free cash flow per share
$-0.03
↓ -29.8%
Long-Term Debt Long-term obligations
$3.19M
↓ -7.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
9
Returns
8
Financial Health
52
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 70 quarters